N-acetylsphingosine is a lipid of Sphingolipids (SP) class. N-acetylsphingosine is associated with abnormalities such as Morphologically altered structure, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and Gigantism. The involved functions are known as inhibitors, anti-apoptosis, Apoptosis, Dephosphorylation and immunoreactivity. N-acetylsphingosine often locates in Plasma membrane, Mitochondria, Pore, Membrane and Cytoplasmic matrix. The associated genes with N-acetylsphingosine are EGR3 gene, CFB gene, FATE1 gene, P4HTM gene and PFDN4 gene. The related lipids are Sphingolipids, Cardiolipins, Glycerophospholipids, dihydroceramide and Phosphatidic Acid.
To understand associated biological information of N-acetylsphingosine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
N-acetylsphingosine is suspected in Morphologically altered structure, protrusion, DERMATITIS HERPETIFORMIS, FAMILIAL, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with N-acetylsphingosine
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ahn EH and Schroeder JJ | Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide. | 2010 | Anticancer Res. | pmid:20683027 |
Lu CY et al. | Docosahexaenoic acid down-regulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes via the sphingomyelinase/ceramide pathway. | 2010 | J. Nutr. Biochem. | pmid:19427778 |
Arboleda G et al. | Differential regulation of AKT, MAPK and GSK3β during C2-ceramide-induced neuronal death. | 2010 | Neurotoxicology | pmid:20696185 |
Abrahan CE et al. | Synthesis of sphingosine is essential for oxidative stress-induced apoptosis of photoreceptors. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:19797232 |
Chen JY et al. | Additive effects of C(2)-ceramide on paclitaxel-induced premature senescence of human lung cancer cells. | 2010 | Life Sci. | pmid:20624405 |
Ferrari D et al. | Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation. | 2010 | Biochem. Biophys. Res. Commun. | pmid:19941832 |
Raucci FJ et al. | Exogenous and endogenous ceramides elicit volume-sensitive chloride current in ventricular myocytes. | 2010 | Cardiovasc. Res. | pmid:20008476 |
Yoon BS et al. | Optimal suppression of protein phosphatase 2A activity is critical for maintenance of human embryonic stem cell self-renewal. | 2010 | Stem Cells | pmid:20306465 |
Pozuelo-Rubio M | Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis. | 2010 | FEBS J. | pmid:20618440 |
Galluzzi L et al. | miR-181a and miR-630 regulate cisplatin-induced cancer cell death. | 2010 | Cancer Res. | pmid:20145152 |